• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢交界性肿瘤中CA125升高是否提示预后不良?一例病例报告。

May increased CA125 in borderline ovarian tumor be indicative of a poor prognosis? A case report.

作者信息

Anastasi Emanuela, Porpora Maria Grazia, Pecorella Irene, Bernardo Silvia, Frati Luigi, Benedetti Panici Pierluigi, Manganaro Lucia

机构信息

Department of Molecular Medicine, Sapienza University of Rome, Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome, Italy,

出版信息

Tumour Biol. 2014 Jul;35(7):6969-71. doi: 10.1007/s13277-014-1898-9. Epub 2014 Apr 17.

DOI:10.1007/s13277-014-1898-9
PMID:24740561
Abstract

We present a case of a 58-year-old menopausal woman referred to our hospital for the presence of large pelvic masses diagnosed by clinical examination and pelvic ultrasound. MRI examination showed voluminous bilateral capsulated multilocular ovarian cysts slightly hyperintense on T1-weighted images with thick septa and small papillary projections. CT scan confirmed the MRI findings. Among the ovarian tumor markers analyzed (CA125, HE4, and CA72.4), only Ca125 was slightly increased (48 U/ml). These data were suggestive of mucinous ovarian tumor. The patient underwent total hysterectomy with bilateral salpingo-oophorectomy, appendectomy, and multiple peritoneal biopsies. Pathological examination revealed bilateral borderline mucinous ovarian tumor with superficial atypical implants. Nine months later, the patient complained of left coxofemoral pain and underwent a PET/TC total body that suggested pubic bone metastases. Ovarian tumor markers were analyzed, and a second PET/TC was performed. CA125 was 252 U/ml, HE4 62 pM/L, and CA72.4 > 100 U/Ml. PET/TC was suggestive of peritoneal carcinosis. The patient was readmitted to the hospital. Clinical examination revealed small vaginal nodules. All nodules were excised. Microscopic analysis of all specimens revealed metastatic mucinous adenocarcinoma of intestinal type.The case shows that even a slight CA125 increase in the presence of a borderline ovarian tumor should not be overlooked since it can be indicative of a progressive disease. This case also highlights its additional diagnostic value when serum CA125 analysis is used in conjunction with MRI and CT imaging for the prognosis of mucinous borderline ovarian tumors (mBOTs).

摘要

我们报告一例58岁的绝经后女性,因临床检查及盆腔超声诊断出盆腔有巨大肿块而转诊至我院。MRI检查显示双侧有大量包膜的多房性卵巢囊肿,在T1加权图像上呈轻度高信号,伴有厚分隔和小乳头样突起。CT扫描证实了MRI的结果。在所分析的卵巢肿瘤标志物(CA125、HE4和CA72.4)中,只有Ca125略有升高(48 U/ml)。这些数据提示为黏液性卵巢肿瘤。患者接受了全子宫切除术、双侧输卵管卵巢切除术、阑尾切除术及多次腹膜活检。病理检查显示双侧交界性黏液性卵巢肿瘤伴浅表非典型种植。9个月后,患者主诉左髋股部疼痛,接受了PET/TC全身检查,提示耻骨骨转移。分析了卵巢肿瘤标志物,并进行了第二次PET/TC检查。CA125为252 U/ml,HE4为62 pM/L,CA72.4>100 U/Ml。PET/TC提示腹膜癌。患者再次入院。临床检查发现阴道有小结节。所有结节均被切除。对所有标本的显微镜分析显示为肠型转移性黏液腺癌。该病例表明,即使在交界性卵巢肿瘤存在时CA125略有升高也不应被忽视,因为它可能提示疾病进展。该病例还突出了血清CA125分析与MRI和CT成像联合用于黏液性交界性卵巢肿瘤(mBOTs)预后评估时的额外诊断价值。

相似文献

1
May increased CA125 in borderline ovarian tumor be indicative of a poor prognosis? A case report.卵巢交界性肿瘤中CA125升高是否提示预后不良?一例病例报告。
Tumour Biol. 2014 Jul;35(7):6969-71. doi: 10.1007/s13277-014-1898-9. Epub 2014 Apr 17.
2
[Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Value of Tumor Markers].[卵巢交界性肿瘤:CNGOF临床实践指南 - 肿瘤标志物的价值]
Gynecol Obstet Fertil Senol. 2020 Mar;48(3):277-286. doi: 10.1016/j.gofs.2020.01.015. Epub 2020 Jan 28.
3
Clinical Value of Serum HE4, CA125, CA72-4, and ROMA Index for Diagnosis of Ovarian Cancer and Prediction of Postoperative Recurrence.血清HE4、CA125、CA72-4及ROMA指数在卵巢癌诊断及术后复发预测中的临床价值
Clin Lab. 2019 Apr 1;65(4). doi: 10.7754/Clin.Lab.2018.181030.
4
Borderline ovarian tumours: retrospective analysis of twenty-one cases.卵巢交界性肿瘤:21例回顾性分析
Eur J Gynaecol Oncol. 1998;19(2):182-5.
5
A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.一种多重生物标志物检测方法提高了 HE4 和 CA125 在卵巢肿瘤患者中的诊断性能。
PLoS One. 2020 Oct 19;15(10):e0240418. doi: 10.1371/journal.pone.0240418. eCollection 2020.
6
Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass.联合症状指数、CA125 和 HE4(三联筛查)检测盆腔肿块女性的卵巢癌。
Gynecol Oncol. 2017 Nov;147(2):291-295. doi: 10.1016/j.ygyno.2017.08.020. Epub 2017 Aug 30.
7
Diagnostic accuracy of CA125 and HE4 in ovarian carcinoma patients and the effect of confounders on their serum levels.CA125 和 HE4 对卵巢癌患者的诊断准确性及混杂因素对其血清水平的影响。
Curr Probl Cancer. 2019 Oct;43(5):450-460. doi: 10.1016/j.currproblcancer.2018.12.004. Epub 2019 Jan 16.
8
Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.评估 HE4、CA125、卵巢恶性肿瘤风险算法(ROMA)和恶性肿瘤指数(RMI)在盆腔肿块患者中作为上皮性卵巢癌的诊断工具。
Gynecol Oncol. 2012 Nov;127(2):379-83. doi: 10.1016/j.ygyno.2012.07.106. Epub 2012 Jul 24.
9
Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.CA125/CEA 比值及超声参数在鉴别多房性及多房实性卵巢肿块患者卵巢转移中的作用。
Ultrasound Obstet Gynecol. 2019 Jan;53(1):116-123. doi: 10.1002/uog.19174.
10
No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting.在临床环境中,联合使用 HE4 和 CA125 作为卵巢肿瘤标志物没有益处。
Gynecol Oncol. 2011 Jun 1;121(3):487-91. doi: 10.1016/j.ygyno.2011.02.022. Epub 2011 Mar 21.

引用本文的文献

1
Exosome-related protein CRABP2 is upregulated in ovarian carcinoma and enhances cell proliferation.外泌体相关蛋白CRABP2在卵巢癌中上调并增强细胞增殖。
Discov Oncol. 2022 May 16;13(1):33. doi: 10.1007/s12672-022-00492-3.
2
Comparative study of endometrioid borderline ovarian tumor with and without endometriosis.子宫内膜样交界性卵巢肿瘤伴和不伴子宫内膜异位症的对比研究。
J Ovarian Res. 2018 Aug 11;11(1):67. doi: 10.1186/s13048-018-0440-x.
3
Role of Galectin-3 Combined with Multi- Detector Contrast Enhanced Computed Tomography in Predicting Disease Recurrence in Patients with Ovarian Cancer.

本文引用的文献

1
Current approaches and challenges in managing and monitoring treatment response in ovarian cancer.卵巢癌治疗反应管理与监测的当前方法及挑战
J Cancer. 2014 Jan 1;5(1):25-30. doi: 10.7150/jca.7810.
2
The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer.使用 HE4、CA125 和 CA72-4 生物标志物进行卵巢子宫内膜异位症和上皮性卵巢癌的鉴别诊断。
J Ovarian Res. 2013 Jul 1;6(1):44. doi: 10.1186/1757-2215-6-44.
3
Borderline ovarian tumors: features and controversial aspects.
半乳糖凝集素-3联合多排螺旋CT增强扫描在预测卵巢癌患者疾病复发中的作用
Asian Pac J Cancer Prev. 2017 May 1;18(5):1277-1282. doi: 10.22034/APJCP.2017.18.5.1277.
4
Expression and diagnostic value of HE4 in pancreatic adenocarcinoma.人附睾蛋白4在胰腺腺癌中的表达及诊断价值
Int J Mol Sci. 2015 Jan 29;16(2):2956-70. doi: 10.3390/ijms16022956.
交界性卵巢肿瘤:特征与争议点。
Eur J Obstet Gynecol Reprod Biol. 2013 Mar;167(1):86-9. doi: 10.1016/j.ejogrb.2012.11.002. Epub 2012 Dec 5.
4
HE4 combined with MDCT imaging is a good marker in the evaluation of disease extension in advanced epithelial ovarian carcinoma.人附睾蛋白4(HE4)联合多层螺旋CT(MDCT)成像在评估晚期上皮性卵巢癌的疾病扩散方面是一种良好的标志物。
Tumour Biol. 2012 Oct;33(5):1291-8. doi: 10.1007/s13277-012-0376-5. Epub 2012 Mar 20.
5
Results of the national survey of borderline ovarian tumors in Spain.
Gynecol Oncol. 2007 Mar;104(3):617-22. doi: 10.1016/j.ygyno.2006.10.001. Epub 2006 Nov 16.
6
Best cases from the AFIP: Borderline papillary serous tumor of the right ovary.武装部队病理研究所的最佳病例:右卵巢交界性乳头状浆液性肿瘤。
Radiographics. 2005 Nov-Dec;25(6):1689-92. doi: 10.1148/rg.256055015.
7
Serous and mucinous borderline (low malignant potential) tumors of the ovary.卵巢浆液性和黏液性交界性(低恶性潜能)肿瘤
Am J Clin Pathol. 2005 Jun;123 Suppl:S13-57. doi: 10.1309/J6PXXK1HQJAEBVPM.